Anaplastic Astrocytoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Advanced Cancer
  • +3 more
  • EV3D Assay
  • Little Rock, Arkansas
  • +8 more
2022-03-30
Mar 30, 2022
S
Active, not recruiting
  • High Grade Glioma
  • +3 more
  • Regadenoson 0.05mg
  • +6 more
  • Birmingham, Alabama
  • +2 more
2022-04-07
Apr 7, 2022
N
Recruiting
  • 1p/19q Co-deletion
  • +8 more
  • IMRT (Intensity-Modulated Radiation Therapy)
  • +2 more
  • Birmingham, Alabama
  • +26 more
2022-04-04
Apr 4, 2022
S
Recruiting
  • Anaplastic Astrocytoma
  • +55 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-04-01
Apr 1, 2022
S
Active, not recruiting
  • High Grade Glioma
  • +6 more
  • Birmingham, Alabama
  • +5 more
2022-03-31
Mar 31, 2022
U
Active, not recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
2022-03-15
Mar 15, 2022
N
Suspended
  • Anaplastic Astrocytoma
  • +6 more
  • Dabrafenib Mesylate
  • +2 more
  • Birmingham, Alabama
  • +113 more
2022-03-26
Mar 26, 2022
W
Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-15
Mar 15, 2022
N
Not yet recruiting
  • Anaplastic Astrocytoma
  • +4 more
  • (no location specified)
2022-03-11
Mar 11, 2022
G
Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
    • Lexington, Kentucky
      University of Kentucky
    2022-03-03
    Mar 3, 2022
    P
    Active, not recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
      Roswell Park Comprehensive Cancer Center
    2022-02-15
    Feb 15, 2022
    N
    Active, not recruiting
    • Diffuse Astrocytoma
    • +21 more
    • Orange, California
    • +56 more
    2022-03-02
    Mar 2, 2022
    C
    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    2022-03-01
    Mar 1, 2022
    J
    Active, not recruiting
    • Glioma
    • +3 more
    • autologous tumor lysate-pulsed DC vaccination
    • +2 more
    • Los Angeles, California
      University of Los Angeles, California
    2022-02-16
    Feb 16, 2022
    N
    Active, not recruiting
    • Anaplastic Astrocytoma
    • +5 more
    • Birmingham, Alabama
    • +23 more
    2022-01-28
    Jan 28, 2022
    U
    Active, not recruiting
    • Supratentorial Neoplasms, Malignant
    • +6 more
    • G207
    • Birmingham, Alabama
    • +1 more
    2022-01-28
    Jan 28, 2022
    P
    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    2022-01-27
    Jan 27, 2022
    O
    Recruiting
    • Glioma, Malignant
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    2022-01-11
    Jan 11, 2022
    O
    Active, not recruiting
    • Anaplastic Astrocytoma
    • Recurrent Anaplastic Astrocytoma
    • Birmingham, Alabama
    • +78 more
    2022-01-19
    Jan 19, 2022
    N
    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    2022-01-10
    Jan 10, 2022
    N
    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-30
    Dec 30, 2021
    M
    Active, not recruiting
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    2021-12-07
    Dec 7, 2021
    N
    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    2021-10-28
    Oct 28, 2021
    N
    Suspended
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Bevacizumab and Carboplatin
    • New York, New York
      Lenox Hill Brain Tumor Center
    2021-10-27
    Oct 27, 2021
    N
    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • New York, New York
      Lenox Hill Brain Tumor Center
    2021-10-27
    Oct 27, 2021